IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 92 filers reported holding IGM BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $58,459 | -20.4% | 7,001 | -12.0% | 0.00% | – |
| Q2 2023 | $73,434 | +11.2% | 7,956 | +65.5% | 0.00% | – |
| Q1 2023 | $66,062 | -1.9% | 4,808 | +21.5% | 0.00% | – |
| Q4 2022 | $67,325 | +1246.5% | 3,958 | +1549.2% | 0.00% | – |
| Q3 2022 | $5,000 | -66.7% | 240 | -71.3% | 0.00% | – |
| Q2 2022 | $15,000 | -48.3% | 836 | -23.5% | 0.00% | – |
| Q1 2022 | $29,000 | -98.1% | 1,093 | -97.9% | 0.00% | – |
| Q4 2021 | $1,545,000 | -32.4% | 52,649 | +51.5% | 0.00% | -100.0% |
| Q3 2021 | $2,284,000 | +585.9% | 34,741 | +768.1% | 0.00% | – |
| Q2 2021 | $333,000 | -73.3% | 4,002 | -75.4% | 0.00% | – |
| Q1 2021 | $1,247,000 | +8213.3% | 16,261 | +9245.4% | 0.00% | – |
| Q4 2020 | $15,000 | -96.4% | 174 | -96.9% | 0.00% | – |
| Q3 2020 | $411,000 | +1612.5% | 5,565 | +1561.2% | 0.00% | – |
| Q2 2020 | $24,000 | -85.8% | 335 | -88.8% | 0.00% | – |
| Q1 2020 | $169,000 | -38.1% | 3,002 | -58.1% | 0.00% | – |
| Q4 2019 | $273,000 | – | 7,159 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,334,355 | $97,797,000 | 2.22% |
| Artal Group S.A. | 1,500,000 | $43,995,000 | 1.19% |
| Cormorant Asset Management, LP | 500,000 | $14,665,000 | 0.87% |
| Eagle Bay Advisors LLC | 34,835 | $1,022,000 | 0.65% |
| ENTRUST GLOBAL PARTNERS L L C | 66,172 | $1,940,000 | 0.54% |
| Baker Brothers Advisors | 3,156,102 | $92,568,000 | 0.45% |
| Bruce & Co., Inc. | 55,000 | $1,613,000 | 0.32% |
| Woodline Partners LP | 403,401 | $11,832,000 | 0.17% |
| Virtus ETF Advisers LLC | 5,787 | $170,000 | 0.06% |
| Alkeon Capital Management | 939,035 | $27,542,000 | 0.05% |